The latest updates on our research and how it is improving people’s lives.
The evolving single-cell and spatial technology landscape
17 July 2024
The scTrends consortium has published its first report that sheds light on the current state of the commercial single-cell and spatial genomics industry and its potential impact on drug discovery and patient care.
NDORMS tests AI algorithms for medical diagnoses
3 July 2024
NDORMS has joined RAIQC as one of eight other NHS, industry and academic consortium partners in Trustworthy AI Evaluation.
New PI will study human iron metabolism, kinetics and physiology in health and inflammatory disease
26 June 2024
We welcome Nicole Stoffel who has joined the Botnar Institute as a new Principal Investigator. Nicole will be establishing her group to better understand human iron metabolism, kinetics and physiology with a specific focus on the role iron plays in the immune response and the impact of iron deficiency on vaccine effectiveness.
Maryam Nina Hardy elected as President of the Oxford University Africa Society
24 June 2024
Kennedy DPhil student Maryam Nina Hardy has been elected as President of the Oxford University Africa Society.
Uncovering the cellular secrets of healthy tendons
24 June 2024
Research has unveiled the intricate cellular landscape of healthy human hamstring tendons, shedding new light on this vital yet often overlooked component of our musculoskeletal system.
Psoriasis probe shows high level of arthritis symptoms in patients
19 June 2024
Early results of an international study examining the risk of arthritis for people with psoriasis have shown a high burden of joint symptoms in 712 patients – 25% of the total studied so far.
SITU announces a trio of new trials
18 June 2024
SITU-NDORMS has announced the launch of three major new clinical trials. Funded by the NIHR, these studies are providing evidence for the treatment of chronic low back pain, knee osteoarthritis, and ACL injuries.
New real-world evidence network co-ordination centre for the UK
17 June 2024
Daniel Prieto-Alhambra from NDORMS is to lead a new co-ordination centre for a pilot real-world evidence network to utilise data gathered from multiple UK sources.
Study uncovers how cancer stem cells spread and resist treatment
6 June 2024
NDORMS researchers have identified a critical axis that controls the formation and behaviour of cancer stem cells (CSCs), a subpopulation of cells that influence how lethal the cancer can be, its resistance to chemotherapy, and its ability to spread to other parts of the body.
The Kennedy Institute welcomes Distinguished Investigator Dr Alan Sher
4 June 2024
Alan has spent two months at the Kennedy Institute as a guest of Professor Dame Fiona Powrie. During his visit he has spent his time collaborating with researchers at the Kennedy and other departments in the University, and mentoring young investigators on their career development.
Oxford researchers contribute to report on the future of healthcare
23 May 2024
Prof. Michael Dustin was one of 17 researchers from across Oxford's Medical Sciences and Maths, Physics and Life Sciences Divisions that have contributed to a new report on the future of healthcare, compiled by Citi Global Perspectives & Solutions (Citi GPS).
New therapeutic avenues in bone repair
22 May 2024
An ongoing research collaboration between NDORMS and University of Birmingham researchers has shown that PEPITEM, a naturally occurring peptide (small protein), holds promise as a new therapeutic for osteoporosis and other disorders that feature bone loss, with distinct advantages over existing drugs.
Cracking the genetic code for COVID-19 vaccine effectiveness
21 May 2024
Researchers have unveiled critical insights into how our genetic makeup influences the body's response to COVID-19 vaccines. The study, published in Nature Communications, may open new paths to personalised vaccination strategies.
New Maternity Early Warning Score to be implemented across the NHS
16 May 2024
Researchers in Oxford have developed a new maternity early warning score that is derived from patient data. The new system, which is being rolled out across the English NHS, will help healthcare providers identify and respond to signs of deterioration in pregnant women.
Success for NDORMS at the Vice Chancellor’s Awards
10 May 2024
Dr Anjali Shah from the Botnar Institute won the Research Culture Award, and the Kennedy Histology Team won the Community Partnership Award.
NDORMS researchers awarded Associate Professor title
9 May 2024
The University of Oxford has awarded the title of Associate Professor to Calliope Dendrou and Siim Pauklin.
New study sheds light on the debate surrounding two types of shoulder replacement surgery for osteoarthritis
1 May 2024
A new study has provided valuable insights into the ongoing debate surrounding two types of shoulder replacement surgery: reverse total shoulder replacement and anatomical total shoulder replacement as a treatment for patients with osteoarthritis.
NHS baby check may miss dislocated hips in new-born babies
25 April 2024
A new study has identified that NHS infant checks can miss serious hip abnormalities in new-born babies. Left undetected, these can require complex surgery, and lead to early arthritis. In the UK around 500 infants undergo surgery for dislocated hips which could have been avoidable.
New Study uses AI to predict malaria outbreaks in South Asia
23 April 2024
Researchers from NDORMS in collaboration with international institutions have demonstrated the potential of using environmental measurements and deep learning modeling to predict malaria outbreaks in South Asia. The study offers promising insights into improving early warning systems for one of the world's deadliest diseases.
HIPCARE trial launches in the Philippines
22 April 2024
Prof Matt Costa has just returned from the Philippines, where he launched the new HIPCARE trial with co-lead investigator Prof Irewin Tabu. The first of five Low- and Middle-Income Countries (LMIC) in Asia to take part, eight hospitals in the Philippines will start recruiting patients with fragility fractures of the hip to the study within weeks.